These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 24715618

  • 1. Structural and dynamic properties of amorphous solid dispersions: the role of solid-state nuclear magnetic resonance spectroscopy and relaxometry.
    Paudel A, Geppi M, Mooter GVD.
    J Pharm Sci; 2014 Sep; 103(9):2635-2662. PubMed ID: 24715618
    [Abstract] [Full Text] [Related]

  • 2. Navigating the Solution to Drug Formulation Problems at Research and Development Stages by Amorphous Solid Dispersion Technology.
    Tripathi D, B H MP, Sahoo J, Kumari J.
    Recent Adv Drug Deliv Formul; 2024 Sep; 18(2):79-99. PubMed ID: 38062659
    [Abstract] [Full Text] [Related]

  • 3. Classification of solid dispersions: correlation to (i) stability and solubility (ii) preparation and characterization techniques.
    Meng F, Gala U, Chauhan H.
    Drug Dev Ind Pharm; 2015 Sep; 41(9):1401-15. PubMed ID: 25853292
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. New Development in Understanding Drug-Polymer Interactions in Pharmaceutical Amorphous Solid Dispersions from Solid-State Nuclear Magnetic Resonance.
    Pugliese A, Tobyn M, Hawarden LE, Abraham A, Blanc F.
    Mol Pharm; 2022 Nov 07; 19(11):3685-3699. PubMed ID: 36037249
    [Abstract] [Full Text] [Related]

  • 6. Effect of amorphous phase separation and crystallization on the in vitro and in vivo performance of an amorphous solid dispersion.
    Knopp MM, Wendelboe J, Holm R, Rades T.
    Eur J Pharm Biopharm; 2018 Sep 07; 130():290-295. PubMed ID: 30064702
    [Abstract] [Full Text] [Related]

  • 7. Recent Advances in Understanding the Micro- and Nanoscale Phenomena of Amorphous Solid Dispersions.
    Ricarte RG, Van Zee NJ, Li Z, Johnson LM, Lodge TP, Hillmyer MA.
    Mol Pharm; 2019 Oct 07; 16(10):4089-4103. PubMed ID: 31487183
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Insights into Nano- and Micron-Scale Phase Separation in Amorphous Solid Dispersions Using Fluorescence-Based Techniques in Combination with Solid State Nuclear Magnetic Resonance Spectroscopy.
    Purohit HS, Ormes JD, Saboo S, Su Y, Lamm MS, Mann AKP, Taylor LS.
    Pharm Res; 2017 Jul 07; 34(7):1364-1377. PubMed ID: 28455777
    [Abstract] [Full Text] [Related]

  • 11. Amorphous solid dispersions: a robust platform to address bioavailability challenges.
    Newman A, Nagapudi K, Wenslow R.
    Ther Deliv; 2015 Feb 07; 6(2):247-61. PubMed ID: 25690090
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Analytical and Computational Methods for the Determination of Drug-Polymer Solubility and Miscibility.
    Thakore SD, Akhtar J, Jain R, Paudel A, Bansal AK.
    Mol Pharm; 2021 Aug 02; 18(8):2835-2866. PubMed ID: 34041914
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Delivery of poorly soluble compounds by amorphous solid dispersions.
    Lee TW, Boersen NA, Hui HW, Chow SF, Wan KY, Chow AH.
    Curr Pharm Des; 2014 Aug 02; 20(3):303-24. PubMed ID: 23651395
    [Abstract] [Full Text] [Related]

  • 18. Using Flory-Huggins phase diagrams as a pre-formulation tool for the production of amorphous solid dispersions: a comparison between hot-melt extrusion and spray drying.
    Tian Y, Caron V, Jones DS, Healy AM, Andrews GP.
    J Pharm Pharmacol; 2014 Feb 02; 66(2):256-74. PubMed ID: 24192445
    [Abstract] [Full Text] [Related]

  • 19. Physicochemical and Pharmacokinetic Characterization of Amorphous Solid Dispersion of Meloxicam with Enhanced Dissolution Property and Storage Stability.
    Ochi M, Kimura K, Kanda A, Kawachi T, Matsuda A, Yuminoki K, Hashimoto N.
    AAPS PharmSciTech; 2016 Aug 02; 17(4):932-9. PubMed ID: 27435198
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.